19-11060181-A-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001387283.1(SMARCA4):​c.5001A>T​(p.Gln1667His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q1667R) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

SMARCA4
NM_001387283.1 missense

Scores

1
8
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.788

Publications

0 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23913142).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMARCA4NM_001387283.1 linkc.5001A>T p.Gln1667His missense_variant Exon 35 of 36 ENST00000646693.2 NP_001374212.1
SMARCA4NM_003072.5 linkc.4905A>T p.Gln1635His missense_variant Exon 34 of 35 ENST00000344626.10 NP_003063.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMARCA4ENST00000646693.2 linkc.5001A>T p.Gln1667His missense_variant Exon 35 of 36 NM_001387283.1 ENSP00000495368.1
SMARCA4ENST00000344626.10 linkc.4905A>T p.Gln1635His missense_variant Exon 34 of 35 1 NM_003072.5 ENSP00000343896.4
SMARCA4ENST00000643549.1 linkc.4911A>T p.Gln1637His missense_variant Exon 34 of 35 ENSP00000493975.1
SMARCA4ENST00000541122.6 linkc.4815A>T p.Gln1605His missense_variant Exon 34 of 35 5 ENSP00000445036.2
SMARCA4ENST00000643296.1 linkc.4815A>T p.Gln1605His missense_variant Exon 33 of 34 ENSP00000496635.1
SMARCA4ENST00000644737.1 linkc.4815A>T p.Gln1605His missense_variant Exon 33 of 34 ENSP00000495548.1
SMARCA4ENST00000589677.5 linkc.4812A>T p.Gln1604His missense_variant Exon 34 of 35 5 ENSP00000464778.1
SMARCA4ENST00000643995.1 linkc.4326A>T p.Gln1442His missense_variant Exon 31 of 32 ENSP00000496004.1
SMARCA4ENST00000644963.1 linkc.3555A>T p.Gln1185His missense_variant Exon 27 of 28 ENSP00000495599.1
SMARCA4ENST00000644065.1 linkc.3537A>T p.Gln1179His missense_variant Exon 26 of 27 ENSP00000493615.1
SMARCA4ENST00000642350.1 linkc.3399A>T p.Gln1133His missense_variant Exon 26 of 27 ENSP00000495355.1
SMARCA4ENST00000643857.1 linkc.3165A>T p.Gln1055His missense_variant Exon 24 of 25 ENSP00000494159.1
SMARCA4ENST00000538456.4 linkc.969A>T p.Gln323His missense_variant Exon 7 of 8 3 ENSP00000495197.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
1398584
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
689822
African (AFR)
AF:
0.00
AC:
0
AN:
31574
American (AMR)
AF:
0.00
AC:
0
AN:
35696
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25166
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35730
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79188
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49202
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5446
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1078646
Other (OTH)
AF:
0.00
AC:
0
AN:
57936
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Sep 18, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Q1667H variant (also known as c.5001A>T), located in coding exon 34 of the SMARCA4 gene, results from an A to T substitution at nucleotide position 5001. The glutamine at codon 1667 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this variant remains unclear.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Uncertain
0.064
T
BayesDel_noAF
Benign
-0.15
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.49
T;.;T;.;.;.;.;.;.;.;T;.;.;.;.;.;T;T;.;.;.;.
Eigen
Benign
0.047
Eigen_PC
Benign
-0.049
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.0
.;D;.;.;.;.;D;.;.;.;D;.;D;D;D;D;D;D;D;D;D;D
M_CAP
Pathogenic
0.32
D
MetaRNN
Benign
0.24
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
0.31
D
MutationAssessor
Benign
1.8
L;.;.;.;.;.;.;.;.;.;L;.;.;.;.;.;.;.;.;.;.;.
PhyloP100
0.79
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-1.6
N;.;.;.;.;.;.;.;.;.;N;.;.;.;N;.;.;.;.;.;.;.
REVEL
Uncertain
0.43
Sift
Uncertain
0.0020
D;.;.;.;.;.;.;.;.;.;D;.;.;.;D;.;.;.;.;.;.;.
Sift4G
Benign
0.11
T;.;.;.;.;.;.;.;.;.;T;.;T;T;T;T;T;T;.;.;.;.
Vest4
0.34
ClinPred
0.76
D
GERP RS
0.19
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.34
gMVP
0.68
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs908806258; hg19: chr19-11170857; API